EUVIMEDEUVIMED entdecken
Crossref

Molecular Detection of ESBL Genes in Salmonella Typhi from Clinical Samples in a Tertiary Hospital in Jos, Plateau State, Nigeria

Joseph Nakah, Mathilda Edmund Banwat, Mark Okolo, Abednego Dahal, Yadang Dasohot Maktep, Bello Ozovehe Banimoh, Adoara Okpala, Nanret Kyeswet Suchi, Paul Eshioramhe, Joseph Dasoem, Reward Audu, Daniel Zanyu Egah

Annals of Laboratory and Clinical Medicine · 04.07.2025

DOI: 10.82216/alcm.vol1no2.32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Laboratory and Clinical Medicine, erschienen am 04.07.2025. Verfasst von Joseph Nakah und 11 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emergence of antibiotic-resistant Salmonella Typhi has become a significant public health concern, particularly due to the carriage of Extended-Spectrum β-lactamase (ESBL) genes, whose expression confers resistance to a broad range of β-lactam antibiotics, including third-generation cephalosporins. Among the ESBL genes reported in Salmonella species, derivatives of the TEM and SHV β-lactamase gene families have been found to be present commonly. Other β-lactamase genes such as CTX-M have been increasingly reported, complicating treatment options. Materials and Methods: A total of 40 non-duplicate clinical isolates of Salmonella Typhi were identified phenotypically and confirmed by nested Polymerase Chain Reaction (nested PCR) from blood and stool specimens of patients at a tertiary hospital in Jos, Plateau State, Nigeria. The isolates were screened for ESBL production using the disk diffusion method following the Clinical and Laboratory Standards Institute (CLSI) guidelines. Phenotypic confirmation of ESBL production was performed using the double-disc synergy test. Multiplex PCR was used to detect ESBL genes.

Results

Phenotypic testing for ESBL production identified 14 (35.0%) of the 40 Salmonella Typhi isolates as ESBL-positive. Among the ESBL genes detected, bla-TEM was the most prevalent (85.7%), followed by bla-SHV (21.4%) and bla-CTX-M (14.3%). Conclusion / Recommendations: The results of this study further accentuate the growing concern over the presence and spread of ESBL-producing S. Typhi. This underscores the need for coordinated antimicrobial stewardship, as well as strengthened infection prevention and control measures, to stem the spread of resistant pathogens. There is a need for a coordinated national policy on continuous surveillance and antimicrobial stewardship to control the spread of these resistant strains, ultimately reducing treatment costs, morbidity, and mortality.

Schlagwörter

Salmonella typhiextended-spectrum beta-lactamaseESBL genesblaTEMblaSHVblaCTX-Mantimicrobial resistanceclinical isolatesantimicrobial stewardshipinfection control

Zitieren

APA

Nakah, J., Banwat, M. E., Okolo, M., Dahal, A., Maktep, Y. D., Banimoh, B. O., Okpala, A., Suchi, N. K., Eshioramhe, P., Dasoem, J., Audu, R., & Egah, D. Z. (2025). Molecular Detection of ESBL Genes in Salmonella Typhi from Clinical Samples in a Tertiary Hospital in Jos, Plateau State, Nigeria. Annals of Laboratory and Clinical Medicine. https://doi.org/10.82216/alcm.vol1no2.32

Vancouver

Nakah J, Banwat ME, Okolo M, Dahal A, Maktep YD, Banimoh BO, et al. Molecular Detection of ESBL Genes in Salmonella Typhi from Clinical Samples in a Tertiary Hospital in Jos, Plateau State, Nigeria. Annals of Laboratory and Clinical Medicine. 2025. doi:10.82216/alcm.vol1no2.32

BibTeX
@article{Nakah2025,
  author = {Nakah, Joseph and Banwat, Mathilda Edmund and Okolo, Mark and Dahal, Abednego and Maktep, Yadang Dasohot and Banimoh, Bello Ozovehe and Okpala, Adoara and Suchi, Nanret Kyeswet and Eshioramhe, Paul and Dasoem, Joseph and Audu, Reward and Egah, Daniel Zanyu},
  title = {Molecular Detection of ESBL Genes in Salmonella Typhi from Clinical Samples in a Tertiary Hospital in Jos, Plateau State, Nigeria},
  journal = {Annals of Laboratory and Clinical Medicine},
  year = {2025},
  doi = {10.82216/alcm.vol1no2.32}
}
Kostenlos starten →